Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hormones & cancer

Showing results (1-10 of 324) with videos related to

Pageof 33
Sort By:
Hormones & Cancer|December 16, 2011
Targeted therapies for adrenocortical carcinoma: IGF and beyondMichael J Demeure, Kimberly J Bussey, Lawrence S Kirschner
Hormones & Cancer|December 16, 2011
Steroid profiling by gas chromatography-mass spectrometry and high performance liquid chromatography-mass spectrometry for adrenal diseasesJeffrey G McDonald, Susan Matthew, Richard J Auchus
Hormones & Cancer|July 16, 2011
Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosisNikki L Neubauer, Erin C Ward, Parin Patel, et al.
Hormones & Cancer|July 16, 2011
Expression and relevance of TRPS-1: a new GATA transcription factor in breast cancerJie Qing Chen, Yi Bao, Jennifer Litton, et al.
Hormones & Cancer|July 16, 2011
Prostate cancer stem cells: do they have a basal or luminal phenotype?Norman J Maitland, Fiona M Frame, Euan S Polson, et al.
Hormones & Cancer|July 16, 2011
Role for microRNAs in regulating glucocorticoid response and resistance in multiple myelomaMichael A Tessel, Ashley L Benham, Nancy L Krett, et al.
Hormones & Cancer|July 16, 2011
The role of sex steroid receptors on lipogenesis in breast and prostate carcinogenesis: a viewpointHenri Rochefort, Dany Chalbos
Hormones & Cancer|July 16, 2011
Suppression of metastatic murine ovarian cancer cells by transduced embryonic progenitor cellsMasaki Mandai, Junzo Hamanishi, Kaoru Abiko, et al.
Hormones & Cancer|July 16, 2011
Expression of membrane progesterone receptors (mPR/PAQR) in ovarian cancer cells: implications for progesterone-induced signaling eventsNathan J Charles, Peter Thomas, Carol A Lange
Hormones & Cancer|July 16, 2011
Estrogen receptor alpha phosphorylated at tyrosine 537 is associated with poor clinical outcome in breast cancer patients treated with tamoxifenGeorgios P Skliris, Zoann Nugent, Peter H Watson, et al.
Pageof 33

Showing results (1-10 of 324) with videos related to

Sort By:
Pageof 33
Hormones & Cancer|December 16, 2011
Targeted therapies for adrenocortical carcinoma: IGF and beyondMichael J Demeure, Kimberly J Bussey, Lawrence S Kirschner
Hormones & Cancer|December 16, 2011
Steroid profiling by gas chromatography-mass spectrometry and high performance liquid chromatography-mass spectrometry for adrenal diseasesJeffrey G McDonald, Susan Matthew, Richard J Auchus
Hormones & Cancer|July 16, 2011
Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosisNikki L Neubauer, Erin C Ward, Parin Patel, et al.
Hormones & Cancer|July 16, 2011
Expression and relevance of TRPS-1: a new GATA transcription factor in breast cancerJie Qing Chen, Yi Bao, Jennifer Litton, et al.
Hormones & Cancer|July 16, 2011
Prostate cancer stem cells: do they have a basal or luminal phenotype?Norman J Maitland, Fiona M Frame, Euan S Polson, et al.
Hormones & Cancer|July 16, 2011
Role for microRNAs in regulating glucocorticoid response and resistance in multiple myelomaMichael A Tessel, Ashley L Benham, Nancy L Krett, et al.
Hormones & Cancer|July 16, 2011
The role of sex steroid receptors on lipogenesis in breast and prostate carcinogenesis: a viewpointHenri Rochefort, Dany Chalbos
Hormones & Cancer|July 16, 2011
Suppression of metastatic murine ovarian cancer cells by transduced embryonic progenitor cellsMasaki Mandai, Junzo Hamanishi, Kaoru Abiko, et al.
Hormones & Cancer|July 16, 2011
Expression of membrane progesterone receptors (mPR/PAQR) in ovarian cancer cells: implications for progesterone-induced signaling eventsNathan J Charles, Peter Thomas, Carol A Lange
Hormones & Cancer|July 16, 2011
Estrogen receptor alpha phosphorylated at tyrosine 537 is associated with poor clinical outcome in breast cancer patients treated with tamoxifenGeorgios P Skliris, Zoann Nugent, Peter H Watson, et al.
Pageof 33